Get PT-141 (Bremelanotide) Online in Nebraska | OmniRx Health
Sexual Wellness Treatment in Nebraska
PT-141 (Bremelanotide) is a melanocortin receptor agonist that enhances sexual desire and arousal through the central nervous system — not the vascular system. It is the first non-hormonal treatment for hypoactive sexual desire disorder approved by the FDA.
Key Benefits
- Works through the brain to enhance desire and arousal
- Effective for both men and women
- Addresses root causes of low libido rather than just physical response
- FDA-approved active ingredient (Vyleesi for women)
- Unique central mechanism distinct from PDE5 inhibitors
Who is a Good Candidate?
Men and women experiencing low sexual desire (HSDD), reduced libido, or sexual arousal difficulties who want a centrally-acting treatment that addresses desire rather than just the physical mechanics of sexual function.
Starting from $199/month
Serving Nebraska
Nebraska's strength is in its people—hardworking farmers, innovative entrepreneurs in Omaha, and tight-knit communities across the plains. OmniRx Health serves this Cornhusker spirit by bringing healthcare to where you are. Whether you're in downtown Omaha, cheering for the Huskers in Lincoln, or running a cattle operation in the Sandhills, our telehealth platform connects you with expert care. No more driving hours across the state when you can consult a board-certified provider from your living room.
Our providers are licensed by the Nebraska Board of Medicine and Surgery for comprehensive statewide telehealth services.
Nebraska pharmacies in Omaha, Lincoln, and throughout rural communities ensure prescription access with reliable home delivery.
Nebraska's telehealth regulations support virtual care delivery while ensuring patient safety standards are maintained.
Nebraska insurers cover telehealth services, with ongoing efforts to expand access and ensure fair reimbursement for virtual care.
Frequently Asked Questions
- How does PT-141 work differently from Viagra or Cialis?
- PDE5 inhibitors like sildenafil and tadalafil work by increasing blood flow to the genitals — they improve physical erectile function but do not enhance sexual desire. PT-141 activates melanocortin receptors in the brain that regulate sexual motivation and arousal, addressing the psychological and neurological dimension of sexual response that PDE5 inhibitors do not target.
- Can women use PT-141?
- Yes. PT-141 was originally developed in part to address hypoactive sexual desire disorder (HSDD) in women. Vyleesi (bremelanotide injection) is FDA-approved for premenopausal women with HSDD. It has also demonstrated benefits in men with situational erectile dysfunction related to low desire or performance anxiety.
- How and when is PT-141 administered?
- PT-141 is administered as a subcutaneous injection, typically 45 minutes to 2 hours before anticipated sexual activity to allow sufficient time for central nervous system activation. The injection site is typically the abdomen. Nausea is the most commonly reported side effect and is usually mild and temporary.
- Is telehealth legal in Nebraska?
- Yes, telehealth is legal in Nebraska. The state supports virtual healthcare delivery, enabling licensed providers to offer consultations, prescriptions, and ongoing care remotely.
- Can western Nebraska residents use telehealth?
- Telehealth is essential for western Nebraska, where medical centers may be hours away. Our platform brings specialist care to Scottsbluff, North Platte, and beyond.
- Does Nebraska insurance cover telehealth?
- Most Nebraska health insurance plans cover telehealth visits. Coverage varies by plan, but virtual care is increasingly recognized as a standard healthcare delivery method.